Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[68Ga]Ga-PSMA-HBED-CC PET/CT demonstrates to be superior to ceCT in detecting early treatment response in metastatic clear cell renal cell carcinoma.
Guglielmo P, Gasparro D, Scarlattei M, Baldari G, Bola S, Migliari S, Sammartano A, Maestroni U, Ruffini L. Guglielmo P, et al. Among authors: gasparro d. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3337-3339. doi: 10.1007/s00259-021-05250-1. Epub 2021 Mar 22. Eur J Nucl Med Mol Imaging. 2021. PMID: 33754194 No abstract available.
Synergic role of dual tracer PET/CT with 18F-FDG and 68Ga-PSMA in the detection of papillary renal cell carcinoma recurrence.
Gasparro D, Scarlattei M, Manuguerra R, Guglielmo P, Migliari S, Sammartano A, Baldari G, Maestroni U, Ruffini L. Gasparro D, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Sep-Oct;41(5):322-324. doi: 10.1016/j.remnie.2021.05.004. Epub 2021 May 24. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 36100315 No abstract available.
Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.
Maestroni UV, Campobasso D, Guarino G, Acampora A, Scarlattei M, Ziglioli F, Dinale F, Baldari G, Migliari S, Gasparro D, Ferretti S, Silini EM, Ruffini L. Maestroni UV, et al. Among authors: gasparro d. Chin Clin Oncol. 2023 Jun;12(3):22. doi: 10.21037/cco-23-10. Chin Clin Oncol. 2023. PMID: 37417288 Free article.
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Sternberg CN, Calabrò F, Bracarda S, Cartenì G, Lo Re G, Ruggeri EM, Basso U, Gasparini G, Ciuffreda L, Ferrari V, Bonetti A, Fea E, Gasparro D, Tassinari D, Labianca R, Masini C, Fly K, Zhang K, Hariharan S, Capaccetti B, Porta C. Sternberg CN, et al. Among authors: gasparro d. Oncology. 2015;88(5):273-80. doi: 10.1159/000369256. Epub 2015 Jan 15. Oncology. 2015. PMID: 25592399 Clinical Trial.
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
Bozzetti C, Tiseo M, Lagrasta C, Nizzoli R, Guazzi A, Leonardi F, Gasparro D, Spiritelli E, Rusca M, Carbognani P, Majori M, Franciosi V, Rindi G, Ardizzoni A. Bozzetti C, et al. Among authors: gasparro d. J Thorac Oncol. 2008 Jan;3(1):18-22. doi: 10.1097/JTO.0b013e31815e8ba2. J Thorac Oncol. 2008. PMID: 18166836 Free article.
54 results